Evidence map›Paper›PMID 26691337›Full record

ArticleMicrobial cell factories2015

Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway.

Pavel Dvorak, Lukas Chrast, Pablo I Nikel, Radek Fedr, Karel Soucek, Miroslava Sedlackova, Radka Chaloupkova, Víctor de Lorenzo, Zbynek Prokop, Jiri Damborsky

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 241 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Natural and Synthetic Metabolic Architectures.Chembiochem : a European journal of chemical biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Metabolic engineering ofBiodesign research · 2025
    Article
  10. Article
  11. Regulation of Plant Genes with Exogenous RNAs.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Production of Vitamin BJournal of microbiology and biotechnology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Pavel DvorakLoschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. pdvorak@cnb.csic.es.
Lukas ChrastLoschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. chr@mail.muni.cz.
Pablo I NikelSystems and Synthetic Biology Program, Centro Nacional de Biotecnología CNB-CSIC, Cantoblanco, 28049, Madrid, Spain. pablo.nikel@cnb.csic.es.
Radek FedrInternational Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. fedr@ibp.cz.
Karel SoucekInternational Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. ksoucek@ibp.cz.
Miroslava SedlackovaDepartment of Histology and Embryology, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic. msedl@med.muni.cz.
Radka ChaloupkovaLoschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. radka@chemi.muni.cz.
Víctor de LorenzoSystems and Synthetic Biology Program, Centro Nacional de Biotecnología CNB-CSIC, Cantoblanco, 28049, Madrid, Spain. vdlorenzo@cnb.csic.es.
Zbynek ProkopLoschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. zbynek@chemi.muni.cz.
Jiri DamborskyLoschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. jiri@chemi.muni.cz.
St. Anne's University Hospital Brno · CZCentro Nacional de Biotecnología · ESRECETOX · CZMasaryk University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeterologous expression systems based on promoters inducible with isopropyl-β-D-1-thiogalactopyranoside (IPTG), e.g., Escherichia coli BL21(DE3) and cognate LacI(Q)/P(lacUV5)-T7 vectors, are commonly used for production of recombinant proteins and metabolic pathways. The applicability of such cell factories is limited by the complex physiological burden imposed by overexpression of the exogenous genes during a bioprocess. This burden originates from a combination of stresses that may include competition for the expression machinery, side-reactions due to the activity of the recombinant proteins, or the toxicity of their substrates, products and intermediates. However, the physiological impact of IPTG-induced conditional expression on the recombinant host under such harsh conditions is often overlooked.

resultsThe physiological responses to IPTG of the E. coli BL21(DE3) strain and three different recombinants carrying a synthetic metabolic pathway for biodegradation of the toxic anthropogenic pollutant 1,2,3-trichloropropane (TCP) were investigated using plating, flow cytometry, and electron microscopy. Collected data revealed unexpected negative synergistic effect of inducer of the expression system and toxic substrate resulting in pronounced physiological stress. Replacing IPTG with the natural sugar effector lactose greatly reduced such stress, demonstrating that the effect was due to the original inducer's chemical properties.

conclusionsIPTG is not an innocuous inducer; instead, it exacerbates the toxicity of haloalkane substrate and causes appreciable damage to the E. coli BL21(DE3) host, which is already bearing a metabolic burden due to its content of plasmids carrying the genes of the synthetic metabolic pathway. The concentration of IPTG can be effectively tuned to mitigate this negative effect. Importantly, we show that induction with lactose, the natural inducer of P lac , dramatically lightens the burden without reducing the efficiency of the synthetic TCP degradation pathway. This suggests that lactose may be a better inducer than IPTG for the expression of heterologous pathways in E. coli BL21(DE3).

Indexed as

Escherichia coliIsopropyl ThiogalactosideMetabolic EngineeringMetabolic Networks and PathwaysIsopropyl Thiogalactoside

Identifiers

PMID26691337
PMCPMC4687329
OpenAlexW2200387749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.